Wang Chuan-hang
Department of Andrology, Beijing Sino-Japan Friendship Hospital, China.
Zhonghua Nan Ke Xue. 2006 Apr;12(4):377-80.
This paper reviewed the efficacy and safety of vardenafil, a highly selective phosphodiesterase type 5 (PDE 5) inhibitor, in men with erectile dysfunction who were difficult to treat. Several large-scale studies indicated vardenafil was effective and safe in the treatment of these difficult-to-treat ED patients, including ED with depression or diabetes, ED after radical retropubic prostatectomy, ED caused by spinal cord injury, and sildenafil nonresponders. Vardenafil provides a rational treatment alternative.
本文综述了高选择性5型磷酸二酯酶(PDE 5)抑制剂伐地那非在难治性勃起功能障碍男性患者中的疗效和安全性。多项大规模研究表明,伐地那非在治疗这些难治性勃起功能障碍患者方面有效且安全,这些患者包括伴有抑郁或糖尿病的勃起功能障碍、耻骨后前列腺根治术后勃起功能障碍、脊髓损伤所致勃起功能障碍以及对西地那非无反应者。伐地那非提供了一种合理的治疗选择。